Oxford Instruments and GE Announce Licensing Deal
By HospiMedica staff writers
Posted on 03 Jun 2004
Oxford Instruments Superconductivity (OIS; Abingdon, UK) recently announced an agreement whereby GE Healthcare (Waukesha, WI, USA) will exclusively license in vitro rights to its proprietary dynamic nuclear polarization (DNP) technology for the creation of the world's first DNP nuclear magnetic resonance (NMR) instrument. Posted on 03 Jun 2004
Traditional NMR, although a data-rich method, has always been limited by a lack of sensitivity, causing scientists to look for alternative, and often complicated and expensive ways of tackling this hurdle.
Related Links:
Oxford Instruments Superconductivity
GE Healthcare
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Mobile Patient Lift
Golvo 9000
New
Ambulatory Blood Pressure Monitor
ASPEL 308-508 ABPM
